Advertisement

Topics

'Clear Role' for PARP Inhibitors in Advanced Ovarian Cancer

06:44 EDT 17 Apr 2018 | Medscape

Recent approval of rucaparib gives patients with ovarian cancer another new option for maintenance therapy.
Medscape Oncology

Original Article: 'Clear Role' for PARP Inhibitors in Advanced Ovarian Cancer

NEXT ARTICLE

More From BioPortfolio on "'Clear Role' for PARP Inhibitors in Advanced Ovarian Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...